![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Holcomb Henry
Publisher: Springer Publishing Company
ISSN: 0033-3158
Source: Psychopharmacology, Vol.174, Iss.1, 2004-06, pp. : 136-142
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine making a mark in schizophrenia
Inpharma, Vol. 1, Iss. 1254, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Stamouli SS Yfantis A Lamboussis E Liakouras A Lagari V Tzanakaki M Giailoglou D Legault M Parashos IA
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. :